Keywords: access, medicines, lessons, big, pharma, hiv, crisis

Access to medicines - lessons for "big pharma" from the HIV crisis in Africa

Article | 12 July 2001

Print This

The main lesson that research-based pharmaceutical companies should takefrom the ongoing controversy in South Africa on the issue of access ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in